Global Acetylcysteine Market Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027

Price: 3600/- USD | Published Date: May 21, 2021 |

The global acetylcysteine market size is anticipated to register a significant CAGR of 4.7% during the forecast period from 2021 to 2027 and estimated to reach USD 772 million by 2027. As per the latest research citings presented by the World Health Organization (WHO), it is anticipated that chronic obstructive pulmonary disease will be the 3rd largest cause of death throughout the globe by 2030. The rising prevalence of acetaminophen overdose throughout the globe will further bolster the market growth.

Acetylcysteine is basically a derivative of the cysteine molecule with an acetyl group attached to its amino acid. N-acetyl cysteine is the prodrug of cysteine which is absorbed via the intestines and is vital in replenishing the glutathione reserves of the liver. It is enlisted in the World Health Organization (WHO) list of essential medicines.

Market Segment Insights:

Acetaminophen overdose in presently representing the largest market share in the treatment segment for the acetylcysteine market. The major factor responsible for its market growth is the constant rise in the patients suffering with fever associated with the infectious disease worldwide. Acetaminophen overdose is associated with non-compliance to the doctor’s prescription and in few cases gross negligence with the drug posology pertaining to acetaminophen. Its primary objective is to maintain and replenish the glutathione reserves of the liver and promote the non-toxic metabolism of acetaminophen. Chronic obstructive pulmonary disease (COPD) is a collective term used for the disease of the lower respiratory tract such as chronic bronchitis and emphysema. The clinical manifestation associated with COPD is shortness in breath due to excess secretion of mucus. Acetylcysteine inhalation is beneficial in reducing the adhesiveness and viscosity of the mucus and promotes its expulsion from the lower respiratory tract.

Acetylcysteine Market Size by Treatment

To know more about the study, request sample papers

Hospitals and clinics are leading the end-user segment for the acetylcysteine market. Patients suffering from chronic bronchitis and emphysema need to be immediately admitted to the intensive care unit to stabilize their condition. Intravenous or inhalation dose of acetylcysteine needs to be started immediately as the treatment regimen. Ambulatory surgical centers have gained prominence in the developed regions owing to its ability to treat acetaminophen overdose in patients residing in remote locations.

The acetylcysteine market research report presents the analysis of each segment from 2018 to 2027 considering 2020 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2021 to 2027.

Historical & Forecast Period

  • 2018-19 – Historical Year
  • 2020 – Base Year
  • 2021-2027 – Forecast Period

Global Acetylcysteine Market Segmentation:

By Treatment:

  • Acetaminophen Overdose
  • Chronic Pulmonary Obstructive Disease (COPD)
  • Dietary Supplement

By End-User:

  • Hospital and Clinics
  • Ambulatory Surgical Centers
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Geographic Coverage:

North America currently dominating the geography segment for the acetylcysteine market. As per the latest research citings brought forward by the Center for Disease Control and Prevention (CDC) the death rate of chronic pulmonary obstructive disease in the United States is approximately 44.3 per 100,000 people each year. Furthermore, the presence of key players such as Fresenius Kabi USA, LLC, Arbor Pharmaceuticals LLC, Teva Pharmaceutical Industries Ltd., Sandoz, Inc. etc further propels the market growth in the region. Europe is placed in the 2nd position in the regional segment on account of the favorable reimbursement scenario for acetylcysteine used for the treatment of acute liver failure in the region. The Asia Pacific is anticipated to be the fastest-growing regional segment in the acetylcysteine market. The rising prevalence of acetaminophen overdose on account of noncompliance to physician’s prescription and flourishing generic drugs market together with determining the acetylcysteine market growth in the region.

Market Competition Assessment:

Some of the major players operating in the global acetylcysteine market are Fresenius Kabi USA, LLC, Arbor Pharmaceuticals LLC, Zambon Group, Sandoz, Inc., and Menarini Group. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

List of Key Companies:

  • Fresenius Kabi USA, LLC.
  • Arbor Pharmaceuticals LLC
  • Zambon Group
  • Sandoz, Inc.
  • Menarini Group
  • Teva Pharmaceutical Industries Ltd.
  • IBSA Farmaceutici
  • Sanofi S.A.
  • Nippon Rika Co., Ltd.
  • Cipla Limited

Key Questions Answered by Acetylcysteine Market Report:

  • Global acetylcysteine market forecasts from 2021-2027
  • Regional acetylcysteine market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
  • Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
  • Acetylcysteine submarket forecasts from 2021-2027 covering the market by treatment, by end-user, and geography
  • Various industry models such as SWOT analysis, Value Chain Analysis pertaining to the acetylcysteine market
  • Analysis of the key factors driving and restraining the growth of the global, regional, and country-level acetylcysteine markets from 2021-2027
  • Competitive Landscape and market positioning of top 10 players operating in the acetylcysteine market
Table of Content:

1. Preface


1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

 

2. Executive Summary


2.1. Global Acetylcysteine Market Portraiture
2.2. Global Acetylcysteine Market, by Treatment, 2020 (USD Mn)
2.3. Global Acetylcysteine Market, by End-User, 2020 (USD Mn)
2.4. Global Acetylcysteine Market, by Geography, 2020 (USD Mn)

 

3. Global Acetylcysteine Market Analysis


3.1. Acetylcysteine Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. COVID-19 Impact Analysis
3.6.1. V Shaped Recovery
3.6.2. U Shaped Recovery
3.6.3. L Shaped Recovery
3.6.4. W Shaped Recovery

 

4. Global Acetylcysteine Market By Treatment, 2018 – 2027 (USD Mn)


4.1. Overview
4.2. Acetaminophen Overdose
4.3. Chronic Pulmonary Obstructive Disease (COPD)
4.4. Dietary Supplement

 

5. Global Acetylcysteine Market By End-User, 2018 – 2027 (USD Mn)


5.1. Overview
5.2. Hospital and Clinics
5.3. Ambulatory Surgical Centers
5.4. Others

 

6. North America Acetylcysteine Market Analysis and Forecast, 2018 – 2027 (USD Mn)


6.1.1. Overview
6.1.2. North America Acetylcysteine Market by Treatment (2018-2027 USD Mn)
6.1.3. North America Acetylcysteine Market by End-User (2018-2027 USD Mn)
6.1.4. North America Acetylcysteine Market by Country (2018-2027 USD Mn)
6.1.4.1. U.S.
6.1.4.1.1. U.S. Acetylcysteine Market by Treatment (2018-2027 USD Mn)
6.1.4.1.2. U.S. Acetylcysteine Market by End-User (2018-2027 USD Mn)
6.1.4.2. Canada
6.1.4.2.1. Canada Acetylcysteine Market by Treatment (2018-2027 USD Mn)
6.1.4.2.2. Canada Acetylcysteine Market by End-User (2018-2027 USD Mn)

 

7. Europe Acetylcysteine Market Analysis and Forecast, 2018 – 2027 (USD Mn)


7.1.1. Overview
7.1.2. Europe Acetylcysteine Market by Treatment (2018-2027 USD Mn)
7.1.3. Europe Acetylcysteine Market by End-User (2018-2027 USD Mn)
7.1.4. Europe Acetylcysteine Market by Country (2018-2027 USD Mn)
7.1.4.1. Germany
7.1.4.1.1. Germany Acetylcysteine Market by Treatment (2018-2027 USD Mn)
7.1.4.1.2. Germany Acetylcysteine Market by End-User (2018-2027 USD Mn)
7.1.4.2. U.K.
7.1.4.2.1. U.K. Acetylcysteine Market by Treatment (2018-2027 USD Mn)
7.1.4.2.2. U.K. Acetylcysteine Market by End-User (2018-2027 USD Mn)
7.1.4.3. France
7.1.4.3.1. France Acetylcysteine Market by Treatment (2018-2027 USD Mn)
7.1.4.3.2. France Acetylcysteine Market by End-User (2018-2027 USD Mn)
7.1.4.4. Italy
7.1.4.4.1. Italy Acetylcysteine Market by Treatment (2018-2027 USD Mn)
7.1.4.4.2. Italy Acetylcysteine Market by End-User (2018-2027 USD Mn)
7.1.4.5. Rest of Europe
7.1.4.5.1. Rest of Europe Acetylcysteine Market by Treatment (2018-2027 USD Mn)
7.1.4.5.2. Rest of Europe Acetylcysteine Market by End-User (2018-2027 USD Mn)

 

8. Asia Pacific Acetylcysteine Market Analysis and Forecast, 2018 – 2027 (USD Mn)


8.1.1. Overview
8.1.2. Asia Pacific Acetylcysteine Market by Treatment (2018-2027 USD Mn)
8.1.3. Asia Pacific Acetylcysteine Market by End-User (2018-2027 USD Mn)
8.1.4. Asia Pacific Acetylcysteine Market by Country (2018-2027 USD Mn)
8.1.4.1. China
8.1.4.1.1. China Acetylcysteine Market by Treatment (2018-2027 USD Mn)
8.1.4.1.2. China Acetylcysteine Market by End-User (2018-2027 USD Mn)
8.1.4.2. Japan
8.1.4.2.1. Japan Acetylcysteine Market by Treatment (2018-2027 USD Mn)
8.1.4.2.2. Japan Acetylcysteine Market by End-User (2018-2027 USD Mn)
8.1.4.3. Rest of Asia Pacific
8.1.4.3.1. Rest of Asia Pacific Acetylcysteine Market by Treatment (2018-2027 USD Mn)
8.1.4.3.2. Rest of Asia Pacific Acetylcysteine Market by End-User (2018-2027 USD Mn)

 

9. Latin America (LATAM) Acetylcysteine Market Analysis and Forecast, 2018 – 2027 (USD Mn)


9.1.1. Overview
9.1.2. Latin America Acetylcysteine Market by Treatment (2018-2027 USD Mn)
9.1.3. Latin America Acetylcysteine Market by End-User (2018-2027 USD Mn)
9.1.4. Latin America Acetylcysteine Market by Country (2018-2027 USD Mn)
9.1.4.1. Brazil
9.1.4.1.1. Brazil Acetylcysteine Market by Treatment (2018-2027 USD Mn)
9.1.4.1.2. Brazil Acetylcysteine Market by End-User (2018-2027 USD Mn)
9.1.4.2. Mexico
9.1.4.2.1. Mexico Acetylcysteine Market by Treatment (2018-2027 USD Mn)
9.1.4.2.2. Mexico Acetylcysteine Market by End-User (2018-2027 USD Mn)
9.1.4.3. Rest of Latin America
9.1.4.3.1. Rest of Latin America Acetylcysteine Market by Treatment (2018-2027 USD Mn)
9.1.4.3.2. Rest of Latin America Acetylcysteine Market by End-User (2018-2027 USD Mn)

 

10. Middle East and Africa Acetylcysteine Market Analysis and Forecast, 2018 – 2027 (USD Mn)


10.1.1. Overview
10.1.2. MEA Acetylcysteine Market by Treatment (2018-2027 USD Mn)
10.1.3. MEA Acetylcysteine Market by End-User (2018-2027 USD Mn)
10.1.4. Middle East and Africa Acetylcysteine Market, by Country (2018-2027 USD Mn)
10.1.4.1. GCC
10.1.4.1.1. GCC Acetylcysteine Market by Treatment (2018-2027 USD Mn)
10.1.4.1.2. GCC Acetylcysteine Market by End-User (2018-2027 USD Mn)
10.1.4.2. Rest of MEA
10.1.4.2.1. Rest of MEA Acetylcysteine Market by Treatment (2018-2027 USD Mn)
10.1.4.2.2. Rest of MEA Acetylcysteine Market by End-User (2018-2027 USD Mn)

 

11. Company Profiles


11.1. Fresenius Kabi USA, LLC.
11.1.1. Business Description
11.1.2. Financial Health and Budget Allocation
11.1.3. Product Positions/Portfolio
11.1.4. Recent Development
11.1.5. SWOT Analysis
11.2. Arbor Pharmaceuticals LLC
11.2.1. Business Description
11.2.2. Financial Health and Budget Allocation
11.2.3. Product Positions/Portfolio
11.2.4. Recent Development
11.2.5. SWOT Analysis
11.3. Zambon Group
11.3.1. Business Description
11.3.2. Financial Health and Budget Allocation
11.3.3. Product Positions/Portfolio
11.3.4. Recent Development
11.3.5. SWOT Analysis
11.4. Sandoz, Inc.
11.4.1. Business Description
11.4.2. Financial Health and Budget Allocation
11.4.3. Product Positions/Portfolio
11.4.4. Recent Development
11.4.5. SWOT Analysis
11.5. Menarini Group
11.5.1. Business Description
11.5.2. Financial Health and Budget Allocation
11.5.3. Product Positions/Portfolio
11.5.4. Recent Development
11.5.5. SWOT Analysis
11.6. Teva Pharmaceutical Industries Ltd.
11.6.1. Business Description
11.6.2. Financial Health and Budget Allocation
11.6.3. Product Positions/Portfolio
11.6.4. Recent Development
11.6.5. SWOT Analysis
11.7. IBSA Farmaceutici
11.7.1. Business Description
11.7.2. Financial Health and Budget Allocation
11.7.3. Product Positions/Portfolio
11.7.4. Recent Development
11.7.5. SWOT Analysis
11.8. Sanofi S.A.
11.8.1. Business Description
11.8.2. Financial Health and Budget Allocation
11.8.3. Product Positions/Portfolio
11.8.4. Recent Development
11.8.5. SWOT Analysis
11.9. Nippon Rika Co., Ltd.
11.9.1. Business Description
11.9.2. Financial Health and Budget Allocation
11.9.3. Product Positions/Portfolio
11.9.4. Recent Development
11.9.5. SWOT Analysis
11.10. Cipla Limited
11.10.1. Business Description
11.10.2. Financial Health and Budget Allocation
11.10.3. Product Positions/Portfolio
11.10.4. Recent Development
11.10.5. SWOT Analysis
Fill the given form to inquiry before buying for Acetylcysteine Market Report

(Additional country analysis and conmapny analysis will be added according to the request, we provide free report customization)
(Report covers the impact of COVID-19 on the market)

Request Report Sample
Inquiry Before Buying


Select License Type
$ 3600/- Single User License
$ 4800/- Multi User License
$ 6800/- Corporate License

Paypal Certified Payment
Why To Choose Us:
  • Markets in over 100+ countries analyzed granularly
  • 35% of our total client are returning clients
  • 1000+ customers globally
  • 100+ paid data sources mined to bring cutting-edge insights
  • 24x5 availability - we are always there when you need us
  • "Free of Cost Report Customization" is available
  • Request a regional report at Best Price
  • Our expert team will assist you with all research need and customization
  • Our expert research analysts will resolve your every query before and after purchasing the report

Impacts of COVID-19
COVID-19 Impact on the Acetylcysteine Market


Our Clients